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Heme oxygenase-1 derived carbon monoxide permits
maturation of myeloid cells
B Wegiel*,1, A Hedblom1,2, M Li1, D Gallo1, E Csizmadia1, C Harris1, Z Nemeth1,5, BS Zuckerbraun4, M Soares3, JL Persson2
and LE Otterbein1
Critical functions of the immune system are maintained by the ability of myeloid progenitors to differentiate and mature into
macrophages. We hypothesized that the cytoprotective gas molecule carbon monoxide (CO), generated endogenously by heme
oxygenases (HO), promotes differentiation of progenitors into functional macrophages. Deletion of HO-1, specifically in the
myeloid lineage (Lyz-Cre:Hmox1flfl), attenuated the ability of myeloid progenitors to differentiate toward macrophages and
decreased the expression of macrophage markers, CD14 and macrophage colony-stimulating factor receptor (MCSFR).
We showed that HO-1 and CO induced CD14 expression and efficiently increased expansion and differentiation of myeloid cells
into macrophages. Further, CO sensitized myeloid cells to treatment with MCSF at low doses by increasing MCSFR expression,
mediated partially through a PI3K-Akt-dependent mechanism. Exposure of mice to CO in a model of marginal bone marrow
transplantation significantly improved donor myeloid cell engraftment efficiency, expansion and differentiation, which
corresponded to increased serum levels of GM-CSF, IL-1a and MCP-1. Collectively, we conclude that HO-1 and CO in part are
critical for myeloid cell differentiation. CO may prove to be a novel therapeutic agent to improve functional recovery of bone
marrow cells in patients undergoing irradiation, chemotherapy and/or bone marrow transplantation.
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Myeloid cells have a critical role in the innate and adaptive
immune system responses to danger signals and pathogens.1
Upon recognition of pathogens or danger-associated mole-
cular patterns (DAMPs), myeloid cells mature into macro-
phages, secrete proinflammatory cytokines, and provide
appropriate inflammatory responses to infection and injury.2
As such, the differentiation status of myeloid cells is critical for
proper phagocytic function and elimination of pathogens. The
process by which myeloid progenitor cells differentiate into
monocytes and eventually into fully mature macrophages
requires the concerted activation and repression of several
lineage-specific genes such as PU.1, GATA2, and c-myb,
among others. Functional maturation of myeloid cells is of
particular importance in situations requiring acute responses
such as during chemotherapy, bone marrow transplantation
or sepsis.
Numerous reports have shown that the heme degradation
pathway regulates immune system responses. It has been
reported that HO-1 and CO induce erythroid differentiation
leading to increased production of hemoglobin and survival of
differentiated cells under low oxygen tension.3 HO-1 has also
been shown to inhibit myoblast differentiation through
downregulation of Lin-28, DGCR8 and heme synthesis.4
In addition, HO-1 favors development of mesenchymal stem
cells toward adipocytes by blocking lipid accumulation,
PPARg and CD13 expression through the Wnt pathway.5 In
contrast, HO-1 has been shown to accelerate mesenchymal
stem cell differentiation toward an osteoblast linage.5 Bone
marrow (BM)-derived stem cells expressing HO-1 are
important for improved myocardial repair following reperfu-
sion injury in the heart.6
We have previously shown that CO induces differentiation
and mobilization of BM progenitors toward an endothelial cell
phenotype in response to vascular injury to accelerate healing
of an injured vessel.7 HO-1 and CO are now recognized as
salutary molecules that reestablish homeostasis following
acute and chronic inflammation such as that associated with
ischemia–reperfusion injury, hemorrhagic and septic shock,
autoimmune disease, inflammatory bowel disease and acute
lung injury.8,9 Many of these pathological conditions require
rapid response of the bone marrow and mobilization of
progenitor cells that contribute to tissue repair. While several
studies have linked HO-1 with stem and progenitor cell
differentiation, we hypothesized that heme degradation may
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be important in early expansion, differentiation, and matura-
tion of myeloid cells into macrophages. Using a model of
marginal bone marrow transplant, which leads to tissue
damage, we find that HO-1-derived and exogenously deliv-
ered CO modulates in part the fate of myeloid progenitors
and mediates the ability of these cells to differentiate into
functional mature cells.
Results
Lack of HO-1 in myeloid cells results in poor maturation
of macrophages. Comparative immunostaining with
antibodies against the residential macrophage marker
F4.80 was performed on the spleens, lungs, and livers
from Hmox1 / and Hmox1þ /þ mice. We observed
significantly lower F4.80-positive counts in Hmox1 /
spleens versus Hmox1þ /þ with no differences in expression
in either the lung or liver (Figures 1a and b). The enlarged
spleens with abnormal white and red pulp typically seen in
Hmox1 / may explain in part the difference in the
macrophage counts and phenotype. We therefore next
focused on deletion of HO-1, specifically in myeloid cells.
Analysis of spleens from Lyz-Cre:Hmox1flfl mice showed no
significant difference in surface expression of F4.80 in the
liver or brain or any of the lymphoid organs including the
spleen, thymus, and lymph nodes (Supplementary Figures
1b and 2). In contrast, we observed lower expression of
CD14, Mac3, and MCSFR in the spleens from Lyz-
Cre:Hmox1flfl mice as compared with Hmox1flfl mice
(Figure 1c and d). Further, lymph nodes and thymus from
Lyz-Cre:Hmox1flfl mice showed lower total expression of
CD14 as measured by immunoblotting and immunostaining,
and a significant difference in surface CD14 expression was
seen in the lymph nodes as measured by FACS (see also
Figure 1d and Supplementary Figure 3 versus
Supplementary Figure 1). These observations, in addition
to decreased circulating CD14þ cell numbers in
Lyz-Cre:Hmox1flfl mice support the hypothesis that HO-1 is
important in maturation of myeloid progenitor cells into a
monocyte/macrophage lineage (Figures 1e and f). Moreover,
the differential expression patterns of CD14 observed in the
thymus, lymph nodes, and spleen suggest that CD14 in
Figure 1 Lack of HO-1 in myeloid cells results in lower number of mature macrophages. (a) Immunohistochemistry with antibody against F4.80 in the spleens, lungs, and livers
from Hmox1 / and Hmox1þ /þ mice. Number of F4.80-positive cells per field of view (n¼ 4–6) was evaluated. Inset: Representative staining is shown. n¼ 3 per group.
**Po0.001 Hmox1 / versus Hmox1þ /þ . (b) Immunohistochemistry of the spleens from Hmox1 / and Hmox1þ /þ mice with staining against CD14. Representative
sections are shown. (c) Immunostaining with antibodies against CD14 (Alexa-488) was performed on the spleen sections from Hmox1flfl and CreLyz:Hmox1flfl mice. n¼ 3–4 per
group. (d) Immunoblotting in the lysates of the spleens from Hmox1flfl and CreLyz:Hmox1flflmice. Antibodies against CD14, Mac3, and MCFR were applied to test for macrophages
maturation. b-Actin was used as loading control. n¼ 4 mice per group. (e, f) Blood cells were isolated by Ficol extraction from Hmox1flfl and CreLyz:Hmox1flfl mice (n¼ 2–3 per
group) and stained against CD14 conjugated with FITC. Appropriate IgG-FITC control antibodies were used. Representative flow cytometry plots are shown in e, and quantitation of
fluorescent mean is shown in f. ANOVA, P¼ 0.0026; Tukey’s test: **Po0.01 Hmox1flfl versus IgG and *Po0.05 Hmox1flfl versus CreLyz:Hmox1flfl
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macrophage is differentially regulated by HO-1 at the total
protein level (in thymus and spleen) versus surface expres-
sion (lymph node and blood).
HO-1 regulates macrophage differentiation. HO-1 is
expressed in various hematopoietic cells in the BM,
including Lin /Sca1þ , Lin /Sca1 , and Linþ populations
(Figures 2a–c). The highest level of HO-1 expression was
observed in Sca1þ /Lin populations, suggesting that HO-1
might have a role in maintaining the stemness features of
hematopoietic stem and progenitor cells by contributing to
their commitment and differentiation into various lineages
(Figures 2b and c). To test the role of HO-1 during myeloid
cell differentiation and maturation, we quantitated the
number of colonies in methylcellulose medium (MethoCult)
derived from myeloid cells harvested from Lyz-Cre:Hmox1flfl
versus Hmox1flfl mice. No significant differences were
observed in colony numbers between genotypes suggesting
that the ability of BM cells to form colonies was not altered in
the absence of HO-1 (Figure 2d). However, we did observe a
significant decrease in CD14 expression in colony-derived
cells lacking HO-1 when cultured in methylcellulose
medium for 9 days (Figure 2e). These data suggest
HO-1 is important for phenotypic maturation of myeloid
cells into a subset of functional macrophages and support
our in vivo observations, in which monocytes isolated from
Lyz-Cre:Hmox1flfl mice present with low CD14 expression
compared with control Hmox1flfl cells in the spleen and
peripheral blood (Figure 1).
Treatment with macrophage colony-stimulating factor
(MCSF) over 5 days induced differentiation of myeloid cells
characterized by increased expression of HO-1 and macro-
phage maturation markers Mac3 and CD14 (Figure 2f).
Myeloid progenitors from Lyz-Cre:Hmox1flfl treated with
MCSF confirmed that CD14 expression was reduced as
compared to progenitors from Hmox1flfl mice (Figure 2g).
We next evaluated whether the absence of maturation
markers such as CD14 translated to alterations in
macrophage function. Treatment of macrophages with
bacterial lipopolysaccharide (LPS) induced rapid degradation
of IkB regulated by CD14 and toll-like receptor activation.
Bone marrow-derived macrophages (BMDM) from
Lyz-Cre:Hmox1flfl showed low CD14 expression, and a
delayed response to LPS treatment as compared with control
Hmox1flfl macrophages (Supplementary Figure 4).
CO induces myeloid cell expansion and differentiation
in vitro. The effects of HO-1 on maturation and differentia-
tion prompted us to next test the effects of CO, a product of
HO-1 activity, on CD14 expression in response to MCSF. CO
Figure 2 HO-1 dictates bone marrow differentiation toward macrophage linage. (a) Immunohistochemistry with antibody against HO-1 in bone marrow of wild-type mice.
Note the single positive cells in the bone marrow progenitor fraction. (b) Immunofluorescent staining of HO-1 on enriched progenitor cells from the bone marrow in a C57/BL6
mouse. Isolated splenocytes (positive control for HO-1 staining), total bone marrow cells, sca1þ /lin- and sca1-/lin- populations were subjected to cytospin and stained with
antibody against HO-1. Representative pictures from 2 to 3 experiments are shown. (c) Real time PCR was performed in the cell fractions as in b. HO-1 expression per b-Actin
is presented as fold change over total BM levels of HO-1. (d) Total BM cells from Hmox1flfl and CreLyz:Hmox1flflmice were isolated and cultured in methylcellulose medium for
9 days following manufacturer’s protocol. Colony counts in methylcellulose medium were performed on day 9. P40.05, NS (e). Total BM cells from Hmox1flfl and
CreLyz:Hmox1flflmice were isolated and cultured in methylcellulose medium for 9 days following manufacturer’s protocol. Immunoblotting with antibody against CD14 and HO-
1 was performed on cell lysates. Data are representative for 2–3 experiments. (f) BM cells were induced toward macrophage differentiation using MCSF (20 ng/ml). Detection
of HO-1, Mac3, and CD14 was performed by immunoblotting. Cells were harvested on days 0–5 during differentiation. Data are representative for at least three experiments.
(g) BM cells isolated from Hmox1flfl and CreLyz:Hmox1flfl mice were subjected to MCSF-induced differentiation as in f, and the levels of CD14 were measured by
immunoblotting. Note that the levels of CD14 are lower in BM from CreLyz:Hmox1flfl mice as early as day 1. Two different exposures of the same CD14 blot are presented to
better appreciate the changes in early and later time points
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enhanced CD14 and Mac3 expression compared with air
controls in macrophages treated with MCSF to stimulate
differentiation for 6–8 days in culture (Figures 3a and b). To
evaluate the mechanism by which CO influenced CD14
expression, we measured levels of macrophage growth
factor receptor (MCSFR) and tested the effects of CO
exposure on MCSF-induced differentiation. Exposure to CO
resulted in a significant increase in expression of both
surface and total MCSFR expression (Figures 3c and d)
while lack of endogenous CO production in myeloid cells
from Lyz-Cre:Hmox1flfl mice resulted in attenuation of
MCSFR expression. Of note, under these treatment condi-
tions, CO had no effect on HIF1a expression or cytokine
release measured in vitro in macrophages or in vivo in the
lymph nodes (Supplementary Figure 5).
Next, we investigated whether CO might effectively induce
differentiation of myeloid progenitors into macrophages
with lower doses of MCSF. CO significantly increased the
number of fully differentiated macrophage as measured by
morphology (Figures 3e and f). Further, CO amplified
Figure 3 CO accelerates differentiation and maturation of macrophages. (a) BMwas isolated from wild-type mice and stimulated with MCSF in the presence or absence of
CO (250 p.p.m.) for 6 and 8 days. Immunoblotting with antibody against Mac3 and CD14 was performed in the lysates of differentiated macrophages. (b) Immunostaining with
antibody against CD14 in CO differentiated cells cultured in methylcellulose for 9 days. Data are representative for two independent experiments performed in triplicates.
(c) Flow cytometry of BMDM treated with CO for 24 h and cell surface MCSFR was detected. n¼ 3 in duplicates, **Po0.01. (d) Immunoblotting and immunostaining with
antibodies against MCSFR and Mac3 in total BM cells from Hmox1flfl and CreLyz:Hmox1flfl mice differentiated with MCSF (20 ng/ml) for 2, 4, and 5 days. Data are
representative for three independent experiments. Densitometric quantitation is shown in Supplementary Figure 6. (e, f). Macrophage colony formation was tested at
suboptimal levels of MCSF (1 ng/ml) in the presence or absence of CO (250 p.p.m.). Significant increase in the number of CO-induced BMDMwas observed at day 3. Data are
representative for three independent experiments. *Po0.05. (g, h) U937 cells were stimulated with PMA (1, 5, or 10 ng/ml) to induce differentiation toward macrophages.
Representative data are shown in g and quantitation is presented in h. n¼ 3 experiments in triplicates. *Po0.05. CO versus Air at each time point
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macrophage colony counts in response to PMA, an agent that
acts through protein kinase C (PKC) to induce macrophage
differentiation (Figures 3g and h). These findings define a
cellular mechanism by which CO, as a bioactive product of
heme catabolism, influences macrophage differentiation.
CO induces MCSF-induced BM differentiation in part via
PI3K-Akt signaling. CO sensitizes BM cells to lower doses
of MCSF in vitro by increasing expression of MCSFR
(CSF1R). To define the mechanism, we tested the role of
two potential pathways that are known targets of CO in other
cells: sGC-cGMP10 and PI3K-Akt7 that regulate transcription
factor PU.1 to increase MCSFR expression.11 Inhibition of
soluble guanylate cyclase did not attenuate CO-induced
MCSF and CD14 expression nor did it interfere with CO-
increased MCSF-driven colony formation (Figures 4a and b).
In contrast, blockade of PI3K using LY294002, a selective
inhibitor of PI3K, resulted in complete repression of
differentiation and induction of MCSFR both basally as well
as in response to CO suggesting a potential mechanism for
general regulation of myeloid differentiation (Figure 4).
CO increases myeloid cell expansion and differentiation
after marginal bone marrow transplantation. To correlate
our in vitro findings with a relevant in vivo model, we
performed a marginal bone marrow transplantation. Lethally
irradiated mice were reconstituted with an insufficient
number of bone marrow-derived myeloid cells. Poor survival
following irradiation is associated with organ damage and
bacterial sepsis largely due to increased gut permeability in
combination with a lack of properly differentiated hemato-
poietic cells. We know this effect to be abrogated with CO
treatment.12 Treatment of mice with CO for 1 h prior to
marginal bone marrow transplant and then daily thereafter for
1 h resulted in 95–100% survival with increased early bone
marrow engraftment versus controls (Figures 5a–c).12 Of the
cells that engrafted, a significant number were positive for
CD133, a myeloid progenitor surface marker (Figure 5d). In
addition, lethally irradiated BM recipient mice treated with CO
showed a higher number of colony-forming units in the
spleen on day 7 in culture as compared with air-treated
control mice (Figure 6a). The spleens isolated from mice
treated with CO after BM transplantation also showed an
increased number of Ki67 positive cells and a significant
expansion of F4.80-positive myeloid cells (Figure 6b).
Importantly, CO treatment of naı¨ve animals for 1 h was
associated with elevated GM-CSF, IL1a IP-10, and MCP-1
levels in the serum suggesting that an increase in myeloid
cell recruitment and the factors necessary for their differ-
entiation likely explains in part the enhanced survival of
lethally irradiated mice treated with CO (Figure 7).
Discussion
The role of HO-1 and its active products on macrophage
function are well established with numerous reports describ-
ing HO-1 as critical in macrophage activation, proliferation,
and survival.13–17 The majority of these reports, however,
focused on how HO-1 and CO modulated mature macro-
phage function versus understanding their role on myeloid
maturation. Recently, it has becomemore evident that HO-1 is
important in regulating reprogramming and differentiation of
other cell lineages including endothelial progenitors, which
are mobilized from bonemarrow to the site of vessel injury.7,18
Bone marrow cells isolated from Hmox1 / mice generate
fewer endothelial colony-forming cells and respond poorly in
models of angiogenesis and ischemic injury of the heart and
hindlimb.18,19 Importantly, lack of HO-1 was rescued with CO
treatment that enhanced endothelial cell recruitment and
vessel development. While the mode of action of HO-1 is
mediated to a large extent by CO, there is in all likelihood a
contribution of the other HO-1 bioactive products, iron and the
bile pigments to bone marrow physiology and end-organ
tissue function.
We describe here that lack of HO-1 specifically in myeloid
cells reduced their ability to undergo maturation into
differentiated and functional macrophages classified as
such by CD14 and MCSFR expression, two well-accepted
markers of macrophage maturation. These macrophage-
specific markers are not only critical for responses to the
growth factor MCSF (MCSFR) but are important for innate
responses to bacterial endotoxins (CD14). CD14 is a
glycoprotein that binds bacterial LPS and activates a
proinflammatory phenotype essential for phagocytosis
Figure 4 CO-induced differentiation and maturation of macrophages is partially
mediated through PI3K-Akt pathway. (a) Immunoblotting with antibodies against
MCSFR and CD14 at stimulation with suboptimal levels of MCSF (1 ng/ml) in the
presence or absence of CO (250 p.p.m.). Cells were pretreated with LY24009 or
ODQ for 1 h prior treatment with CO. Data are representative for two independent
experiments. (b) Macrophage colony formation was tested in cells treated as above
at day 3. ANOVA, Po0.0001; Tukey’s test: &Po0.01 AirþODQ or Airþ LY
versus Air, *Po0.05 CO versus Air, #Po0.001 COþ LY versus CO, NS CO versus
COþODQ
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Figure 5 CO treatment enhances survival and bone marrow engraftment in marginal bone marrow transplant. (a–c) Representative section of bones and flow cytometry
differential counts of bone marrow cells at day 7 are shown; n¼ 3–4 per group. *Po0.05. (d) Immunohistochemical staining with antibodies against CD133 in the group of CO
and Air-treated mice after marginal bone marrow transplantation at day 7
Figure 6 CO induces early engraftment and expansion of myeloid progenitors in the spleen during marginal bone marrow transplant. (a) Number of colony-forming units in
the spleen in the mice after marginal BM transplant as in Figure 5. *Po0.05 Air versus Naive and #Po0.05 CO versus Air. (b) Immunohistochemistry with antibody against
CD133 (progenitor marker), P-Histone-H3 (proliferation marker), F4.80 (macrophage marker) as well as TUNEL staining (apoptosis) was performed in the spleens as in a
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of pathogens. Macrophages from CD14 / mice are
incapable of clearing apoptotic cells suggesting a broader
role of CD14 in tissue repair following injury.20 Low CD14
levels may explain in part the poor responses of HO-1
knockout mice against bacterial infection and greater organ
damage in models of sepsis.13,21 Others and we have shown
that mice lacking HO-1 in macrophages have a low
phagocytic index whereas exposure to CO can rescue and
augment bacterial recognition and clearance.13,22
We observed significantly less CD14 and MCSFR expres-
sion in mononuclear cells isolated from the spleen and in
peripheral leukocytes from Lyz-Cre:Hmox1flfl mice. This
phenotype might explain in large part the inability of these
mononuclear cells to remove apoptotic bodies and dead
erythrocytes due to impaired phagocytic activity, in combina-
tion with an inability to process heme. However, in contrast to
low numbers of F4.80-positive cells in Hmox1 / mice as
comparedwithHmox1þ /þ mice, we observed no difference in
F4.80 levels when comparing macrophages harvested from
Hmox1flfl versus Lyz-Cre:Hmox1flfl mice. One explanation
may be uncontrolled expansion of the T-cell zone in Hmox1 /
mice with less infiltration and recruitment of macrophages
from the bonemarrow due to abnormal white pulp distribution.
Unlike Hmox1 /mice, Lyz-Cre:Hmox1flfl mice do not present
with enlarged spleens likely because deletion of HO-1 in these
mice is limited to myeloid lineage.
Hematopoietic stem cells (HSC) from Hmox1 / mice
repopulated lethally irradiated recipients, but were ineffective
in affording radioprotection in part due to decreased p38
MAPK activation in HSC in response to oxidative stress.23 Our
studies here show that exogenously applied CO promoted
engraftment and radioprotection in a marginal bone marrow
transplant model. CO augmented expansion of CD133þ
progenitors in secondary myelopoietic organs and early
differentiation of myeloid cells.
Perhaps one of the principal mechanisms of CO action in
myeloid progenitors may be to increase reactive oxygen
species (ROS) and modulate the overall redox status of the
cell. Stem cell niche and progenitor expansion and differ-
entiation are highly regulated by oxygen tension.24–26 Hypoxia
is a general stimulus for bone marrow activation26 and
regulates hematopoiesis in the marrow. The generation
of CO under stress conditions likely reduces oxygen
tension locally in the bone marrow that in turn influences
cellular oxygen sensor signaling and upregulation of
CO-responsive transcription factors such as Bach1 andNPAS2.
Figure 7 Luminex cytokine assay was performed in serum from mice treated with CO (250 p.p.m.) or Air for 1 h. n¼ 5 mice per group. Highly elevated and mildly elevated
cytokines and chemokines are presented in a and b, respectively. *Po0.05 CO versus Air, **Po0.01 CO versus Air
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These signals activate survival pathways, compelling mobiliza-
tion and differentiation of precursor cells into those necessary to
befit the requirements of the body during development and in
response to cellular and tissue stress. The release of specific
mediators, chemokines, and growth factors initiate the
directionality of the ultimate cell type, and we posit that
HO-1, necessary for heme turnover, is ideally situated to
regulate and direct successful transition of an immature
progenitor into a mature and functional differentiated cell
ultimately mediated by CO.27,28 Indeed, CO specifically
increased expression of the growth factors and cytokines
GM-CSF, IP-10, IL1a, as well as the chemokine MCP-1.
Increasedmobilization of progenitors from the bonemarrow in
response to these factors may be an explanation for improved
repair that has been observed in models of wound healing,
cardiac myocyte injury, and endothelial denudation.7,29,30
In summary, wehave shown thatHO-1 andCOare important
in differentiation of myeloid progenitors into a macrophage
phenotype. The precise cellular target remains elusive and
whether these protective molecules influence all progenitor cell
differentiation and mobilization remains to be determined.
Collectively, these data and published reports support sub-
stantial dependence on the milieu of growth factors, chemo-
kines, and cytokines present as well as the presence of other
bioactive gases including nitric oxide and hydrogen sulfide.
Collectively, CO serves to intensify and increase sensitivity to
these mediators to instill specificity and a hierarchy of
differentiation of predisposed cell types. Data presented here
would support the conclusion that CO: (i) promotes recovery
from infection associated with radioablation and loss of the
intestinal barrier, (ii) enhances reconstitution of bone marrow,
and (iii) induces clearance of apoptotic cells more efficiently in
response to radiation so as to allow a more rapid repopulation
of bone marrow. These attributes of CO are supported by work
by others and us showing that CO decreases cell death in part
by increased DNA repair mechanisms.12 Inhaled CO is
currently in multiple clinical trials (http://www.clinicaltrials.gov)
and thus, the potential therapeutic opportunities continue to
increase. The use of CO in patients undergoing bone marrow
transplantation or in patients treated with chemoablative
therapies may show great beneficial effects with a CO
treatment regimen that enables efficient and appropriate
regeneration and differentiation of myeloid cells to maintain
barrier integrity of the host and ensure robust defense systems.
Materials and Methods
Mice. HO-1 knockout mice were previously described.31 Hmox1flfl mice were
obtained from Riken in Japan and were described.32 Hmox1flfl mice were crossed
with CreLyz transgenic mice (Jackson Laboratories, Bar Harbor, ME, USA) to
obtain myeloid-specific deletion of HO-1 in CreLyz:Hmox1flfl mice. Bone marrow
marginal transplant: Mice were treated with CO for 1 h prior to irradiation with
10 Gy, and 2.5 106 total bone marrow cells were transplanted (suboptimal
marginal bone marrow transplant) by i.v. tail injection to the irradiated recipients as
previously described.12 Mice were treated every day for 1 h at 250 p.p.m. CO.
Majority of non-treated recipients did not survive beyond 7 days. CO treatment
lead to 90–100% survival in C57/Bl6 mice. For luminex screen of 13 cytokines and
chemokines, mice (n¼ 5/group) were treated with CO (250 p.p.m.) for 1 h and
sera were collected at this time point.
Cell culture and treatment. U937 cells were purchased from ATTC and
were cultured in RPMI medium supplemented with 10% FBS. PMA (0.1, 1, or
10 ng/ml, Sigma, St. Louis, MO, USA), LY24009 (10 mM), and ODQ (20 nM);
appropriate vehicle controls were used. BM isolation: Bone marrow cells were
isolated from wild type, or CreLyz:Hmox1flfl, Hmox1flfl mice and differentiated
toward macrophages in RPMI medium (Gibco, Life Technologies, Grand Island,
NY, USA) supplemented with 1–20 ng/ml MCSF and 15% fetal bovine serum
(FBS) and antibiotics. All cultures were maintained at 37 1C in a 5% CO2
atmosphere. CO treatment: CO administration was done in 21% O2, 5% CO2, and
250 p.p.m. CO in gas exposure chambers with constant monitoring. Both the
incubator and CO chambers were kept at 37 1C.
Colony-forming assay: Bone marrow differentiation was assessed by using a
methylcellulose-based colony-forming assay according to the manufacturer’s
description (StemCell Technologies, Vancouver, BC, Canada). Isolated bone
marrow was separated for different lineages and counted. Bone marrow cells were
mixed with 3.5 ml of semisolid methylcellulose-based medium (MethoCult GF
M3434) (StemCell Technologies) containing Stem Cell Factor, IL-3, IL-6, and
erythropoietin, and triplicate 1.1 ml aliquots of the cell-containing media was
dispensed into 35-mm dishes (StemCell Technologies). Colony plates were
cultured in incubators at 37 oC, 5% CO2 and 95% humidity in the presence or
absence of CO (250 p.p.m.). Colonies were counted at day 3, 6, 8, and 9 and cells
were harvested for protein analysis.
Mouse bone marrow lineage separation: Bone marrow was isolated by
crushing mice tibias and femurs. The bone marrow cells were thoroughly
separated by repeated pipetting in PBS with 2 mM EDTA and 5% FBS, referred to
as recommended medium by the manufacturer (StemCell Technologies). Cells
were filtered through a 70-mm strainer (BD Biosciences, San Jose, CA, USA) to
obtain single-cell suspensions. Lineage-negative cells were separated from mature
cells by using EasySep Mouse Hematopoietic Progenitor Enrichment Kit (StemCell
Technologies, cat# 19756) according to manufacturer’s protocol. Briefly, lineage
positive cells (Linþ ) were labeled with magnetic microparticles using biotinylated
antibodies against cell surface antibodies, including anti-CD5, CD11b, CD19, CD45R,
Ly-6G, and TER119. The magnetically labeled Linþ cells were then separated from
unlabeled lineage-negative (Lin ) cells using EasySep Magnetic column.
Immunoblotting. Cells or tissues were homogenized and lysed by brief
sonication in lysis buffer (150mM NaCl, 50mM Tris-HCl pH7.5, 1% NP-40, 10mM
NaF, 1% SDS, 1 mM Na-EDTA pH 8.0, 0.5 mM NaDOC and protease inhibitor
cocktail Complete Mini (Roche, Basel, Switzerland) as previously described.33
Samples were centrifuged for 20min at 13 500 g at 4 1C, and clear supernatants
were collected. Protein amount was normalized using the BCA Protein Kit (Pierce,
Thermo Scientific, Rockford, IL, USA), and 20–30mg of total protein of each
sample was subjected to 12% SDS-Page gel electrophoresis, followed by transfer
to PVDF Hybond-P membranes (Amersham, GE Healthcare, Pittsburgh, PA,
USA). Membranes were probed with appropriate primary antibodies followed by
horseradish peroxidase (HRP)-conjugated secondary antibodies (Cell Signaling,
Danvers, MA, USA) diluted 1 : 5000, and visualized using the Enhanced
Chemiluminescence detection system (ECL) and ECL films (Thermo Scientific,
Tewksbury, MA, USA). The following antibodies were used: CD14 (BD
Biosciences, Sparks, MD, USA), Mac3 (BD Biosciences, San Jose, CA, USA),
MSCFR (Cell Signaling), b-actin (Sigma-Aldrich, St. Louis, MO, USA), HO-1 (Abcam,
Cambridge, MA, USA or Epitomics, Burlingame, CA, USA), IL1b (Millipore, Billerica,
MA, USA), and HIF1a (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Immunohistochemistry, TUNEL, and immunofluorescence. The
spleens, lungs, and livers were obtained from Hmox /and CreLyz:Hmox1flfl mice
and either snap frozen in freezing medium followed by cutting into 6mM sections or
fixed in formalin and processed for paraffin embedding and antigen retrial using
citrate buffer as previously described.33 Bones were fixed, decalcified, and paraffin
embedded. After fixation with 2% PFA, sections were permeabilized with 0.5% Triton
X-100, blocked with horse serum, and respective primary antibodies were applied
over night. The following day, secondary antibodies conjugated with Alexa-488 were
applied for 1 h at room temperature. Nuclear staining was done with Hoechst, and
slides mounted on gelvatol. Pictures were taken at 20 or  40 magnification under
confocal microscopy. The following primary antibodies were used: CD14 (BD
Biosciences, San Jose, CA, USA), CD133 (Sigma-Aldrich), HO-1 (Epitomics),
P-Histone-H3 (Cell Signaling), F4.80 (Serotec).
Flow cytometry. Blood cells were isolated on Ficoll as described and stained
with CD14-FITC (Biolegend, San Diego, CA, USA) or MCSF-APC (Biolgened) or
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F4.80-FITC (Biolegend) antibodies at RT for 30min. After washing with PBS,
samples were subjected to flow analysis using Calibur Flow Cytometer (BD
Biosciences, San Jose, CA, USA). Peritoneal cells and bone marrow cells were
harvested, and differential counts were performed by flow cytometry.
Statistical analysis. Statistical analyses were performed using SPSS
version 13.0 (SPSS, Chicago, IL, USA). Data are presented as the mean±S.D.
and are representative for at least three independent experiments. Student’s
t, ANOVA, Wilcoxon tests were used for estimation of statistical significance for the
experiments (Po0.05). Densitometric analysis was performed using ImageJ
software (http://imagej.nih.gov/ij/).
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